Altered modulation of soluble guanylate cyclase in lymphocytes from patients with liver disease

Journal of Molecular Medicine

Volumn 80, Issue 2, 2002, Pages 117-123

  Corbalán, Regina ^a   Miñana, María Dolores ^b   Del Olmo, Juan A ^c   Serra, Miguel A ^c   Rodrigo, José M ^c   Felipo, Vicente ^a  

^a Laboratorio de Neurobiologia de Prince Felipe Research Centre   (Spain)

^b Organismo Público Valenciano de Investigación   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

cGMP; Hepatic encephalopathy; Hyperammonemia; Nitric oxide

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; INTERFERON; NITRIC OXIDE;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME METABOLISM; FEMALE; HEMODYNAMICS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CIRRHOSIS; LIVER DISEASE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SOLUBILITY; TREATMENT OUTCOME;

ADULT; AGED; CYCLIC AMP; ENZYME ACTIVATION; FEMALE; GUANYLATE CYCLASE; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERAMMONEMIA; LIVER DISEASES; LYMPHOCYTES; MALE; MIDDLE AGED; NITRIC OXIDE; SOLUBILITY;

EID: 0036182634     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-001-0286-2     Document Type: Article

References (25)

1. The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylate cyclase by nitric oxide. Potential relevance to regulation of blood pressure
2. Chronic hyperammonemia impairs glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo
3. Altered content and modulation of soluble guanylate cyclase in the cerebellum of rats with portacaval anastomosis
4. Chronic hyperammonemia in rats impairs activation of soluble guanylate cyclase in neurons and in lymphocytes. A putative peripheral marker for neurological alterations
5. Hyperdynamic circulation in cirrhosis: A role for nitric oxide?
6. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation
7. In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure
8. Metallothioneins of monocytes and lympocytes
9. Plasma concentrations of cyclic 3′,5′-guanosine monophosphate in patients with cirrhosis: Relationship with atrial natriuretic peptide and haemodynamics
10. Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion
11. Binding characterization of a putative cGMP transporter in the cell membrane of human erythrocytes
12. Export of guanosine 3′,5′-cyclic monophosphate (cGMP) from human erythrocytes characterized by inside-out membrane vesicles
13. Secretion of cGMP by cultured epithelial and fibroblast cell lines in response to nitric oxide
14. Cyclic GMP efflux from liver slices
15. Atrial natriuretic factor-induced egression of cyclic guanosine 3′,5′-monophosphate in cultured vascular smooth muscle and endothelial cells
16. Role of cyclic GMP in glutamate neurotoxicity in primary cultures of cerebellar neurons
17. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation
18. Increased nitric oxide synthesis and inducible nitric oxide synthase expression in patients with alcoholic and non-alcoholic liver cirrhosis
19. Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients
20. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat
21. Reduced nitric oxide production by endthelial cells in cirrhotic rat liver: Endothelial dysfunction in portal hypertension
22. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension
23. Protein kinase C catalyzes phosphorylation of guanylate cyclase in vitro
24. Evidence for phosphorylation of rat brain guanylate cyclase by cyclic-AMP-dependent protein kinase
25. Activation of soluble guanylate cyclase through phosphorylation by protein kinase C in intact PC12 cells